Development of an improved reporter system for assessing the activity of programmable RNA regulators

14 December 2022, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

RNA-binding proteins (RBPs) play a key role in the control of gene expression through their regulation of mRNA half-life, localization, chemical composition, and translation. Aside from their roles in native biological regulation, RBP functions can also be leveraged to create synthetic RNA regulators by fusing functional components of RBPs to programmable RNA-binding platforms such as RNA-targeting CRISPR-Cas systems or CRISPR-Cas Inspired RNA-targeting System (CIRTS). However, a key bottleneck for developing programmable RNA regulators is a lack of robust reporter systems and methods to characterize their function. To develop better reporters to characterize RNA regulator activity we optimized a dual luciferase reporter system by selecting luciferase enzymes that maximize reproducibility and signal stability. Additionally, we demonstrated that untranslated regions (UTRs) from disease-relevant transcripts could be incorporated into the reporter mRNAs, both to test RBPs in more native sequence contexts, but also to evaluate RBPs ability to affect gene expression from an mRNA when directed to those sequences. We also demonstrate the flexibility of the reporter by tuning its translational efficiency, testing the reporter in multiple cell lines, and by testing validated RNA regulators that target several UTRs from disease-relevant gene targets. The new reporter system showcased here should provide a valuable method to characterize and develop novel RNA regulators for both synthetic biology and therapeutic purposes.

Keywords

RNA
epitranscriptome
CIRTS
CRISPR
Cas
Cas13
transcription
translation

Supplementary materials

Title
Description
Actions
Title
Supporting Information
Description
Supporting Information
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.